Real-World Study Shows Persistence of Erenumab for Preventing Migraine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Headache
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
Headache 2021 Nov 22;[EPub Ahead of Print], J Gladstone, S Chhibber, J Minhas, CS Neish, GS Power, Z Lan, D Rochdi, J Lanthier-Martel, N BastienFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.